Stuttering Clinical Trial
Official title:
Characteristics of Idiopathic Familial Speech Disorders
NCT number | NCT00001551 |
Other study ID # | 960088 |
Secondary ID | 96-N-0088 |
Status | Completed |
Phase | N/A |
First received | November 3, 1999 |
Last updated | June 30, 2017 |
Start date | May 22, 1996 |
Verified date | November 13, 2009 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
According to studies, speech disorders with unknown causes (idiopathic) affect approximately
5% of the population at some point in their life. Some of these disorders like, stuttering
and cluttering, are known for being detected early, during speech development.
Stuttering is characterized by sound and syllable repetitions and consonant/vowel
prolongations. When stuttering is moderate to severe, it can interfere with a person's job
and social activities.
Speech articulation disorders are characterized by omissions, or substitutions of speech
sounds. The speech of a person who clutters is often difficult to understand. People are
often unaware of the errors they make when speaking causing treatment of the condition to be
very difficult.
The purpose of this research is to study an extended family whose members exhibit a pure form
of speech articulation disorders
In addition, the study will use data and information gathered from the study and use it to
develop guidelines (criteria) for defining and differentiating patients with speech
disorders.
Status | Completed |
Enrollment | 375 |
Est. completion date | |
Est. primary completion date | November 13, 2009 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
-INCLUSION CRITERIA: i. Normal Language Development, Hearing and Cognition ii. The following screening tests previously published with norms were found to have a good distribution for determining normal functioning in adolescents and adults as all subjects did not hit ceiling and all had scores greater than or equal to the 80th percentile. These tests are being used to ensure that subjects affected with stuttering or FPPD do not have other disorders such as hearing loss, language delay, or mental retardation. Peabody Picture Vocabulary Test III (PPVT-III) Expressive Vocabulary Test (EVT) Oral Speech Mechanism Screening Examination Revised Token Test; Token test for Children Test of Non verbal intelligence (TONI-2) Digit Span subtest of the WICS-R Audiometric Screening Goldman Fristoe Test of Articulation WUG Test of Morphological Encoding Test of Auditory Comprehension of Language (TACL) Khan-Lewis Phonological Analysis INCLUSION CRITERIA FOR IDENTIFYING AND QUANTIFYING STUTTERING: The Stuttering Severity Index -3 (Riley, 1981) has been found to be accurate for identifying and assessing the severity of stuttering during conversational speech. For the inclusion of a stuttering subject we require: i. A total overall score of 11 or greater between 3 and 17 years, ii. A total overall score of 18 or greater from age 18 and above. INCLUSION CRITERIA FOR IDENTIFYING FPPD: i. A family history of an autosomal dominant pattern of inheritance of the speech disorder over several generations with persistence into adulthood in some cases, ii. Speech symptoms during conversational speech include: deletion of final consonants; syllable reduction and syllable deletion; deletion of grammatical markers such as copulas, auxiliaries, prepositions, connectives; poor ability to self-correct; poor awareness of errors; and consonant cluster reduction. iii. Greater than 9% discourse errors during analysis of a sample of 300 syllables. iv. A discrepancy of 30 points (1 and 1/2 Standard Deviations) between receptive (the higher score) and expressive percentile score on the PPVT III and Expressive Vocabulary Test. v. For subjects greater than 7 years of age, a phonological process rating of 3 or more for any phonological process on the Khan-Lewis Phonological Analysis. For subjects less than 7 years of age, a phonological process rating of 3 or more on 2 phonological processes on the Khan-Lewis Phonological Analysis. Finally, any subjects with a non developmental phonological process error will be identified as potentially having FPPD. EXCLUSION CRITERIA: i. Anyone with a hearing loss will be excluded from participation during the diagnostic testing. ii. Children with delayed language, more than 1 year delay from norms on receptive and expression language testing will be excluded. iii. Language impairment: scores more than 2 standard deviations below the age appropriate score on the standardized language tests listed under the inclusion criteria. iv. Cognitive impairment: scores more than 2 standard deviations below the age appropriate score on the standardized cognitive tests listed under the inclusion criteria. v. Bilingual non-native English speakers - Studies have demonstrated that brain organization for speech and language may differ in bilingual persons. It is hypothesized that this may alter speech motor learning and thus kinematic data from non-native English speakers would differ from native English speakers. Therefore, only native-American English speakers, with only one language spoken in the home, will be included. |
Country | Name | City | State |
---|---|---|---|
United States | University of Maryland, College Park | College Park | Maryland |
United States | University of Wisconsin | Madison | Wisconsin |
Lead Sponsor | Collaborator |
---|---|
National Institute of Neurological Disorders and Stroke (NINDS) |
United States,
Cox NJ, Seider RA, Kidd KK. Some environmental factors and hypotheses for stuttering in families with several stutterers. J Speech Hear Res. 1984 Dec;27(4):543-8. — View Citation
Felsenfeld S, McGue M, Broen PA. Familial aggregation of phonological disorders: results from a 28-year follow-up. J Speech Hear Res. 1995 Oct;38(5):1091-107. — View Citation
Plomin R, Owen MJ, McGuffin P. The genetic basis of complex human behaviors. Science. 1994 Jun 17;264(5166):1733-9. Review. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT01684657 -
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
|
Phase 3 | |
Not yet recruiting |
NCT05437627 -
Computerized Based Analysis for Detection and Severity Assessment of Stuttering
|
||
Completed |
NCT02288598 -
Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering
|
N/A | |
Completed |
NCT00001602 -
Genetic Factors Related to Stuttering
|
N/A | |
Active, not recruiting |
NCT04082104 -
Assessment of Stuttering Severity in Adults and Adolescences in Conversational and Narrative Contexts
|
||
Completed |
NCT04580966 -
IBSR Intervention for Adults Who Stutter
|
N/A | |
Recruiting |
NCT00148161 -
Activity of the Auditory Cortex During Speech Perception and Speech Production in Stuttering
|
N/A | |
Recruiting |
NCT05908123 -
Exploring the Nature, Assessment and Treatment of Stuttering
|
N/A | |
Withdrawn |
NCT01315730 -
The Effects of Tactile Speech Feedback on Stuttering Frequency
|
Phase 1 | |
Completed |
NCT00004991 -
Study of Brain Activity During Speech Production and Speech Perception
|
N/A | |
Recruiting |
NCT05286151 -
Network Connectivity and Temporal Processing in Adolescents Who Stutter
|
N/A | |
Completed |
NCT00001604 -
Genetic Linkage Studies of Stuttering
|
||
Recruiting |
NCT00680303 -
Spacing Lidcombe Program Clinic Visits
|
Phase 2 | |
Recruiting |
NCT00709072 -
Follow-up of Children After Stuttering Treatment
|
Phase 2 | |
Completed |
NCT00830154 -
A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering
|
Phase 2/Phase 3 | |
Completed |
NCT03698539 -
How Stuttering and Gestures Influence the Intelligibility of Individuals With Down Syndrome
|
||
Completed |
NCT04505696 -
Providing Speech Therapy Awareness in Private Schools
|
N/A | |
Recruiting |
NCT04929184 -
Speech Processing in Stuttering
|
N/A | |
Terminated |
NCT00001308 -
Central Mechanisms in Speech Motor Control Studied With H215O PET
|
||
Completed |
NCT01097161 -
Stuttering and Apraxia of Speech: the Efficacy of an Intervention Program
|
N/A |